278 related articles for article (PubMed ID: 23290524)
1. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor.
Zuo W; Huang F; Chiang YJ; Li M; Du J; Ding Y; Zhang T; Lee HW; Jeong LS; Chen Y; Deng H; Feng XH; Luo S; Gao C; Chen YG
Mol Cell; 2013 Feb; 49(3):499-510. PubMed ID: 23290524
[TBL] [Abstract][Full Text] [Related]
2. DNA Damage Activates TGF-β Signaling via ATM-c-Cbl-Mediated Stabilization of the Type II Receptor TβRII.
Li Y; Liu Y; Chiang YJ; Huang F; Li Y; Li X; Ning Y; Zhang W; Deng H; Chen YG
Cell Rep; 2019 Jul; 28(3):735-745.e4. PubMed ID: 31315051
[TBL] [Abstract][Full Text] [Related]
3. De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II.
Jacko AM; Nan L; Li S; Tan J; Zhao J; Kass DJ; Zhao Y
Cell Death Dis; 2016 Nov; 7(11):e2474. PubMed ID: 27853171
[TBL] [Abstract][Full Text] [Related]
4. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
Zhang H; Liu ZG; Hua XX
Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
[TBL] [Abstract][Full Text] [Related]
5. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of TGF-beta type II receptor isoforms contributes to acute myeloid leukemia.
Wu Y; Su M; Zhang S; Cheng Y; Liao XY; Lin BY; Chen YZ
Oncotarget; 2017 Feb; 8(6):10037-10049. PubMed ID: 28052022
[TBL] [Abstract][Full Text] [Related]
7. HILI inhibits TGF-β signaling by interacting with Hsp90 and promoting TβR degradation.
Zhang K; Lu Y; Yang P; Li C; Sun H; Tao D; Liu Y; Zhang S; Ma Y
PLoS One; 2012; 7(7):e41973. PubMed ID: 22848678
[TBL] [Abstract][Full Text] [Related]
8. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
McLean S; Di Guglielmo GM
Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
[TBL] [Abstract][Full Text] [Related]
9. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction.
McLean S; Bhattacharya M; Di Guglielmo GM
Cell Signal; 2013 Jan; 25(1):319-31. PubMed ID: 23069267
[TBL] [Abstract][Full Text] [Related]
10. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
11. TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.
Kim YW; Park J; Lee HJ; Lee SY; Kim SJ
Biochem J; 2012 Aug; 445(3):403-11. PubMed ID: 22571197
[TBL] [Abstract][Full Text] [Related]
12. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
13. IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.
Liu C; Billadeau DD; Abdelhakim H; Leof E; Kaibuchi K; Bernabeu C; Bloom GS; Yang L; Boardman L; Shah VH; Kang N
J Clin Invest; 2013 Mar; 123(3):1138-56. PubMed ID: 23454766
[TBL] [Abstract][Full Text] [Related]
14. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational Modifications of TGF-β Receptors.
Yan X; Chen YG
Methods Mol Biol; 2016; 1344():49-61. PubMed ID: 26520117
[TBL] [Abstract][Full Text] [Related]
16. Dlg5 interacts with the TGF-β receptor and promotes its degradation.
Sezaki T; Tomiyama L; Kimura Y; Ueda K; Kioka N
FEBS Lett; 2013 Jun; 587(11):1624-9. PubMed ID: 23624079
[TBL] [Abstract][Full Text] [Related]
17. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
Deng X; Bellis S; Yan Z; Friedman E
Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
[TBL] [Abstract][Full Text] [Related]
18. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract][Full Text] [Related]
19. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M
Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490
[TBL] [Abstract][Full Text] [Related]
20. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
